Nature of the Event
The shareholders have approved the re-appointment of Shri Dilip H. Bhuta (DIN:03157252) as the Whole Time Director and CFO (Key Managerial Personnel) of the company.
Key Quantitative Figures and Dates
- Age of Appointee: 74 years
- Term of Re-appointment: 05 (Five) years from 01st April, 2027 to 31st March, 2032
- Remuneration Period: 03 (three) years from 1st April, 2027 to 31st March, 2030
- Current Tenure End Date: 31st March, 2027
- Original Appointment Date: 16th July 2013
Brief Profile of the Appointee
Shri Dilip H. Bhuta is a Bachelor of Commerce degree holder and a certified Associate of Indian Institute of Bankers (CAIIB). He joined Bank of Baroda on 9th June 1970 and retired on 31st January 2012 after a 42-year tenure where he worked in various positions including clerk, officer, branch head, deputy regional manager, regional manager (Kanpur region), inspection head, and managing director of BOB Cards Ltd. (a subsidiary of Bank of Baroda). At Jenburkt Pharmaceuticals, he looks after all aspects of finance, operations and allied activities at the Head Office. He attended all meetings of the Board and Committees of the Company held during the financial year 2025-26.
Relationships and Compliance Disclosures
Shri Dilip H. Bhuta is not related to any Director / Key Managerial Personnel of the Company. He is neither debarred from holding the office of director by virtue of any SEBI order or any other authority, nor disqualified under section 164 of the Companies Act, 2013.
Additional Information
The complete details are enclosed as Annexure - A and the information is also available on the company's website at www.Jenburkt.com.